Logo image of HCWC

HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis

USA - NYSEARCA:HCWC - US42227T1051 - Common Stock

0.5698 USD
-0.03 (-4.83%)
Last: 11/7/2025, 8:04:00 PM
0.575 USD
+0.01 (+0.91%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, HCWC scores 3 out of 10 in our fundamental rating. HCWC was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. HCWC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, HCWC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HCWC has reported negative net income.
HCWC had a positive operating cash flow in the past year.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.38%, HCWC is doing worse than 79.49% of the companies in the same industry.
Looking at the Return On Equity, with a value of -47.80%, HCWC is doing worse than 79.49% of the companies in the same industry.
Industry RankSector Rank
ROA -8.38%
ROE -47.8%
ROIC N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

With an excellent Gross Margin value of 39.73%, HCWC belongs to the best of the industry, outperforming 87.18% of the companies in the same industry.
HCWC's Gross Margin has improved in the last couple of years.
HCWC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HCWC remains at a similar level compared to 1 year ago.
The debt/assets ratio for HCWC is higher compared to a year ago.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

HCWC has an Altman-Z score of 2.25. This is not the best score and indicates that HCWC is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.25, HCWC is doing worse than 71.79% of the companies in the same industry.
The Debt to FCF ratio of HCWC is 3.53, which is a good value as it means it would take HCWC, 3.53 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.53, HCWC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 1.10 is on the high side and indicates that HCWC has dependencies on debt financing.
HCWC has a Debt to Equity ratio of 1.10. This is in the lower half of the industry: HCWC underperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.53
Altman-Z 2.25
ROIC/WACCN/A
WACC9.25%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

HCWC has a Current Ratio of 0.98. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.98, HCWC is doing worse than 74.36% of the companies in the same industry.
HCWC has a Quick Ratio of 0.98. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, HCWC perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.53
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

6

3. Growth

3.1 Past

HCWC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.68%, which is quite impressive.
The Revenue has grown by 24.57% in the past year. This is a very strong growth!
The Revenue has been growing by 83.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.73%
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%4.45%

3.2 Future

Based on estimates for the next years, HCWC will show a very strong growth in Earnings Per Share. The EPS will grow by 24.21% on average per year.
HCWC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.78% yearly.
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

2

4. Valuation

4.1 Price/Earnings Ratio

HCWC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HCWC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HCWC indicates a slightly more expensive valuation: HCWC is more expensive than 74.36% of the companies listed in the same industry.
94.87% of the companies in the same industry are more expensive than HCWC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.28
EV/EBITDA 38.57
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

HCWC's earnings are expected to grow with 24.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HCWC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (11/7/2025, 8:04:00 PM)

After market: 0.575 +0.01 (+0.91%)

0.5698

-0.03 (-4.83%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)10-20 2025-10-20/bmo
Earnings (Next)N/A N/A
Inst Owners1.19%
Inst Owner Change1.58%
Ins Owners14.76%
Ins Owner Change0%
Market Cap7.86M
Revenue(TTM)79.15M
Net Income(TTM)-2.83M
Analysts82.86
Price Target2.04 (258.02%)
Short Float %1.39%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.76%
Min EPS beat(2)-47.06%
Max EPS beat(2)70.59%
EPS beat(4)3
Avg EPS beat(4)21.22%
Min EPS beat(4)-47.06%
Max EPS beat(4)70.59%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-6.91%
Max Revenue beat(2)5.83%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-6.91%
Max Revenue beat(4)5.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF 3.28
P/OCF 2.86
P/B 1.33
P/tB N/A
EV/EBITDA 38.57
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.17
FCFY30.47%
OCF(TTM)0.2
OCFY34.98%
SpS5.74
BVpS0.43
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.38%
ROE -47.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.73%
FCFM 3.03%
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score7
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.53
Debt/EBITDA 18.91
Cap/Depr 20.56%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion 795.89%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.53
Altman-Z 2.25
F-Score7
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.73%
EPS Next Y37.14%
EPS Next 2Y24.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%4.45%
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A

HEALTHY CHOICE WELLNESS CORP / HCWC FAQ

What is the fundamental rating for HCWC stock?

ChartMill assigns a fundamental rating of 3 / 10 to HCWC.


What is the valuation status of HEALTHY CHOICE WELLNESS CORP (HCWC) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHY CHOICE WELLNESS CORP (HCWC). This can be considered as Overvalued.


How profitable is HEALTHY CHOICE WELLNESS CORP (HCWC) stock?

HEALTHY CHOICE WELLNESS CORP (HCWC) has a profitability rating of 2 / 10.


How financially healthy is HEALTHY CHOICE WELLNESS CORP?

The financial health rating of HEALTHY CHOICE WELLNESS CORP (HCWC) is 2 / 10.